Chenkai Hu

Dr. Chenkai Hu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2025 in International Journal of Biological Sciences
Verified
Journal Article
Open access
PDF file
CHChenkai Hu
Chenkai Hu
WHWan-Zhong Huang
Wan-Zhong Huang
LHLei He
Lei He
CCChen Chang
Chen Chang
YRYan-Ling Ren
Yan-Ling Ren
QSQiang Su
Qiang Su
Coronary microembolization (CME) refers to embolism in the coronary microcirculation. This study showed a reduction in succinyl transferase (CPT1A) and the succinylation substrate (succinyl-CoA) in cardiomyocytes in CME models, suppressing the succinylation of the mitochondrially localized protein TRMT10C. Suppression of succinylation promotes KPNA4 recognition of two nuclear localization signals (NLSs), KAKR and KKK(X)10KVKK, in TRMT10C, which induces the transport of TRMT10C from the cytoplasm to the nucleus rather than to the mitochondria. Nuclear TRMT10C induces YTHDF2-mediated decay of TAFAZZIN and NLRX1 through m1A modifications. The reduction in TAFAZZIN and NLRX1 is associated with multiple detrimental effects, such as inflammation mediated by NF-κB and NLRP3, reactive oxygen species (ROS) production, and suppression of mitophagy. TRMT10C knockdown suppressed the accumulation of TRMT10C in the nucleus. It restored NLRX1 and TAFAZZIN protein levels in cardiomyocytes under hypoxia. However, the deficiency of TRMT10C in the mitochondria did not improve—or even worsened—with TRMT10C knockdown. Inducing TRMT10C succinylation via CPT1A overexpression led to the redistribution of TRMT10C to the mitochondria rather than the nucleus, which is likely a better approach for improving cardiomyocyte function under hypoxia than direct TRMT10C knockdown. This study reveals a novel pathological mechanism underlying CME and suggests potential therapeutic targets for this disease.

1 June 2022 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
CHChenkai Hu
Chenkai Hu
RCRu-Ping Cai
Ru-Ping Cai
LHLei He
Lei He
SHShi-Rong He
Shi-Rong He
JLJun-Yu Liao
Jun-Yu Liao
QSQiang Su
Qiang Su
Background: Studies have shown that percutaneous coronary intervention (PCI) is considered as the essential therapeutic strategy for the patients with ST-segment elevation myocardial infarction (STEMI). However; no-reflow could still occur in a few patients after PCI. Studies have reported that biomarkers related to no-reflow pathogenetic components could play a prognostic role in the prediction phenomenon. Hence, this study explored the establishment of nomogram model for predicting the occurrence of no-reflow phenomenon after PCI using the lncRNA TUG1/miR-30e/NPPB biomarkers in patients with STEMI after PCI. Methods: In this observational study, a total of 76 STEMI patients who underwent emergency PCI between January 2018 and December 2021were included. The patients after PCI, were divided into reflow (n=44) and no-reflow groups (n=32). The demographic, environmental and clinical risk factors were assessed and analysed between the groups. Quantitative RT-PCR was used to detect TUG1, miR-30e, and NPPB messenger RNA (mRNA) expression levels in the plasma of patients after PCI. Bioinformatic methods were used to predict the interaction of the plasma TUG1/miR-30e/NPPB axis. The risk factors in the no-reflow group were screened using a logistic-regression analysis, and a nomogram prediction model was constructed and validated. Subsequently, a gene set enrichment analysis revealed the function of lncRNA TUG1. Results: Plasma lncRNA TUG1 and NPPB were more highly expressed and miR-30e was more lowly expressed in the no-reflow group than the normal-reflow group (P<0.001). A negative correlation was observed between lncRNA TUG1 and miR-30e, and between miR-30e and NPPB. However, a positive correlation was observed between lncRNA TUG1 and NPPB mRNA. The bioinformatics analysis predicted multiple binding sites on the lncRNA TUG1 and miR-30e. LncRNA TUG1 [odds ratio (OR): 0.163, 95% confidence interval (CI): 0.021–0.944] and hs-CRP (OR: 2.151, 95% CI: 1.536–3.974) found to be as independent predictors. The C-index of this prediction model was 0.982 (95% CI: 0.956–1.000). Conclusions: TUG1 could function as an effective biomarker for no-reflow among patients with STEMI after PCT and the proposed nomogram may provide information for individualized treatment in patients with STEMI.

10 October 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
YHYuanqing He
Yuanqing He
ZLZhenhuan Lyu
Zhenhuan Lyu
YMYayue Mai
Yayue Mai
SLSi Li
Si Li
CHChenkai Hu
Chenkai Hu
Coronary artery segmentation in X-ray angiography is clinically critical for percutaneous coronary intervention (PCI), as it offers essential morphological guidance for stent deployment, stenosis assessment, and hemodynamic optimization. Nevertheless, inherent angiographic limitations, including complex vasculature, low contrast, and fuzzy boundaries, persist as significant challenges. Current methodologies exhibit notable shortcomings, including fragmented output continuity, noise susceptibility, and computational inefficiency. This study proposes VM-CAGSeg, a novel U-shaped architecture integrating vessel structure-aware state space modeling, to address these limitations. The framework introduces three key innovations: (1) A Vessel Structure-Aware State Space (VSASS) block that synergizes geometric priors from a Multiscale Vessel Structure-Aware (MVSA) module with long-range contextual modeling via Kolmogorov–Arnold State Space (KASS) blocks. The MVSA module enhances tubular feature representation through Hessian eigenvalue-derived vesselness measures. (2) A Cross-Stage Feature Interaction Fusion (CSFIF) module that replaces conventional skip connections with cross-stage feature fusion strategies to enhance the variability of learned features, preserving long-range dependencies and fine-grained details. (3) A unified architecture that integrates the Vessel Structure-Aware State Space (VSASS) block and the Cross-Stage Feature Interaction Fusion (CSFIF) module to achieve comprehensive vessel segmentation by synergizing multiscale geometric awareness, long-range dependency modeling, and cross-stage feature refinement. Experiments demonstrate that VM-CAGSeg achieves state-of-the-art performance, surpassing CNN-based (e.g., UNet++), transformer-based (e.g., MISSFormer), and state space model (SSM)-based (e.g., H_vmunet) methods, with a Dice similarity coefficient (DSC) of 88.15%, mIoU of 79.19%, and a 95% Hausdorff distance (HD95) of 13.68 mm. The framework significantly improved boundary delineation, reducing HD95 by 49.8% compared to UNet++ (27.15 mm) and by 16.6% compared to TransUNet (15.85 mm). While its sensitivity (90.05%) was marginally lower than that of TransUNet (90.33%), the model's balanced performance in segmentation accuracy and edge precision confirmed its robustness. These findings validate the effectiveness of integrating multiscale vessel-aware modeling, long-range dependency learning, and cross-stage feature fusion, making VM-CAGSeg a reliable solution for clinical vascular segmentation tasks that require fine-grained detail preservation. The proposed method is available as an open-source project at https://github.com/GIT-HYQ/VM-CAGSeg.